Aesthetic Medical International Holdings Group Limited (AIH) is a publicly traded company in the Healthcare sector, operating within the Medical - Care Facilities industry. The company is headquartered in Shenzhen, China. The current CEO is Pengwu Zhou.
AIH has IPO date of 2019-10-25, 1,286 full-time employees, listed on the NASDAQ Global Market, a market capitalization of $15.93M.
Aesthetic Medical International Holdings Group Limited provides aesthetic medical services. It offers surgical aesthetic treatments, such as eye surgery, rhinoplasty, breast augmentation, and liposuction; and non-surgical aesthetic treatments comprising minimally invasive and energy-based treatments, including laser, ultrasound, and ultraviolet light treatments. The company also provides general healthcare and other aesthetic medical services, such as internal medicine, urology, gynecology, and obstetrics treatment services, as well as dentistry, dermatology, and hair loss treatment services. It operates 15 treatment centers in China, Hong Kong, and Singapore. Aesthetic Medical International Holdings Group Limited was founded in 1997 and is headquartered in Shenzhen, the People's Republic of China.
